BR112021017188A2 - Composição farmacêutica de inibidor da prolil hidroxilase e método de preparação do mesmo - Google Patents

Composição farmacêutica de inibidor da prolil hidroxilase e método de preparação do mesmo

Info

Publication number
BR112021017188A2
BR112021017188A2 BR112021017188A BR112021017188A BR112021017188A2 BR 112021017188 A2 BR112021017188 A2 BR 112021017188A2 BR 112021017188 A BR112021017188 A BR 112021017188A BR 112021017188 A BR112021017188 A BR 112021017188A BR 112021017188 A2 BR112021017188 A2 BR 112021017188A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
prolyl hydroxylase
hydroxylase inhibitor
preparation
present application
Prior art date
Application number
BR112021017188A
Other languages
English (en)
Inventor
Lei Shi
Luying Wang
Zhiliang Yang
Original Assignee
Jiangsu Hengrui Medicine Co
Suzhou Suncadia Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co, Suzhou Suncadia Biopharmaceuticals Co Ltd filed Critical Jiangsu Hengrui Medicine Co
Publication of BR112021017188A2 publication Critical patent/BR112021017188A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

composição farmacêutica de inibidor da prolil hidroxilase e método de preparação do mesmo. o presente pedido fornece uma composição farmacêutica de um inibidor da prolil hidroxilase e um método de preparação da mesma. em particular, o presente pedido fornece uma composição compreendendo um composto representado pela fórmula (i) ou um sal farmaceuticamente aceitável do mesmo e pelo menos um produto de enchimento hidrossolúvel. a composição fornecida pelo presente pedido tem taxa de dissolução rápida e boa estabilidade.
BR112021017188A 2019-03-04 2020-03-03 Composição farmacêutica de inibidor da prolil hidroxilase e método de preparação do mesmo BR112021017188A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910160454 2019-03-04
PCT/CN2020/077560 WO2020177681A1 (zh) 2019-03-04 2020-03-03 一种脯氨酰羟化酶抑制剂的药物组合物及其制备方法

Publications (1)

Publication Number Publication Date
BR112021017188A2 true BR112021017188A2 (pt) 2021-11-09

Family

ID=72337018

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021017188A BR112021017188A2 (pt) 2019-03-04 2020-03-03 Composição farmacêutica de inibidor da prolil hidroxilase e método de preparação do mesmo

Country Status (10)

Country Link
US (1) US20220160693A1 (pt)
EP (1) EP3936119A1 (pt)
JP (1) JP2022523782A (pt)
KR (1) KR20210135527A (pt)
CN (1) CN113056262B (pt)
AU (1) AU2020233045A1 (pt)
BR (1) BR112021017188A2 (pt)
CA (1) CA3131445A1 (pt)
TW (1) TW202100153A (pt)
WO (1) WO2020177681A1 (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105130888A (zh) * 2015-10-09 2015-12-09 中国药科大学 炔基吡啶类脯氨酰羟化酶抑制剂、其制备方法和医药用途

Also Published As

Publication number Publication date
CN113056262A (zh) 2021-06-29
EP3936119A1 (en) 2022-01-12
CA3131445A1 (en) 2020-09-10
CN113056262B (zh) 2022-11-18
JP2022523782A (ja) 2022-04-26
KR20210135527A (ko) 2021-11-15
AU2020233045A1 (en) 2021-10-21
TW202100153A (zh) 2021-01-01
WO2020177681A1 (zh) 2020-09-10
US20220160693A1 (en) 2022-05-26

Similar Documents

Publication Publication Date Title
MX2022015207A (es) Compuestos antivirales para tratar infecciones por coronavirus, picornavirus, y norovirus.
BR112019003504A2 (pt) compostos de amino-pirrolopirimidinona e métodos de uso dos mesmos
BR112013032928A2 (pt) "derivados de maitansinoide com ligante de peptídeo e conjugados dos mesmos, composição farmacêutica que os compreende e uso dos mesmos"
EA038122B9 (ru) Ингибитор поверхностного антигена вируса гепатита b
MX2019011693A (es) Compuestos que inhiben la proteina mcl-1.
TN2018000395A1 (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
MX371167B (es) Inhibidores de inhibidores del factor beta de crecimiento de transformacion (tgf-beta).
BR112013004368A2 (pt) compostos tendo a fórmula geral (i) e composição farmacêutica
WO2020113213A3 (en) Cyclic pantetheine derivatives and uses thereof
WO2008024301A3 (en) Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
BR112016030733A2 (pt) Derivados de indano e indolina e uso dos mesmos como ativadores de guanilato ciclase solúveis
BR112021022536A2 (pt) Derivado de fenilpropenilpiridina substituída e método de preparação do mesmo e uso médico do mesmo
BR112016007078A2 (pt) composto tendo atividade agonística do receptor de somatostatina e uso farmacêutico do mesmo
MX2021003686A (es) Medicamento para el tratamiento de la tos cronica.
MY146042A (en) Water-soluble benzoazepine compound and its pharmaceutical composition
BR112015026840A2 (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia
BR112021023927A2 (pt) Composto, e, composição farmacêutica
CY1124643T1 (el) Νεα ενωση και φαρμακευτικα αποδεκτο αλας αυτης
MX2022001789A (es) Derivados de 2-hidroxicicloalcan-1-carbamoilo.
SA519410865B1 (ar) مركب حلقي شبيه بكُومارين بوصفه مثبط mek واستخدامه
MX2022006519A (es) Medicamento conjugado con polietilenglicol, metodo de preparacion del mismo y uso del mismo.
BR112022002784A2 (pt) Compostos tetracíclicos e sais do mesmo, composições e métodos para uso do mesmo
MX2023013225A (es) Inhibidores de la cinasa 4 similar a polo.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]